Evidence mapPaperPMID 41996347Full record

ReviewPhysiology (Bethesda, Md.)2026

Novel roles of GPCRs in the renal collecting duct.

Mackenzie K Kui, Jessica J Zhang, Jennifer L Pluznick

Abstract readReview
In one paragraph

Review in Physiology (Bethesda, Md.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mackenzie K KuiDepartment of Physiology, Pharmacology, and Therapeutics, Johns Hopkins, Baltimore, Maryland, USA.
Jessica J ZhangDepartment of Physiology, Pharmacology, and Therapeutics, Johns Hopkins, Baltimore, Maryland, USA.
Jennifer L PluznickDepartment of Physiology, Pharmacology, and Therapeutics, Johns Hopkins, Baltimore, Maryland, USA.ORCID 0000-0003-2188-4629

Funding

MULTIDISCIPLINARY TRAINING PROGRAM IN LUNG DISEASEST32HL007534 · NHLBI · JOHNS HOPKINS UNIVERSITY · 1985 to 2025
$8.7M
Olfactory Receptor 558 (OLFR558) Ligands and Blood Pressure RegulationR01DK137762 · JOHNS HOPKINS UNIVERSITY · 2025 to 2025
$622k
Sex Differences in Blood Pressure and Olfactory Receptor 558 (OLFR558)R01DK139021 · JOHNS HOPKINS UNIVERSITY · 2025 to 2025
$616k
Uncovering the Role of GPR39 in the kidneyF31DK137460 · JOHNS HOPKINS UNIVERSITY · 2025 to 2025
$40k
HHS | NIH | NIDDK | Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM) F31DK137460HHS | NIH | NIDDK | Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM) R01DK137762HHS | NIH | NIDDK | Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM) R01DK139021HHS | NIH | NIDDK | Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM) T32HL007534Johns Hopkins University (JHU) Dean's ASPIRE Grant for Undergraduate ResearchNHLBI NIH HHS T32 HL007534NIDDK NIH HHS F31 DK137460NIDDK NIH HHS R01 DK137762NIDDK NIH HHS R01 DK139021
6 · The paper itself

Abstract

GPCRs serve to coordinate renal collecting duct function, orchestrating fine-tuned regulation of water, electrolyte, and acid-base homeostasis. Classical GPCRs such as the vasopressin V2 receptor (V2R) have well-established roles: the V2R serves to regulate water reabsorption, and V2R dysregulation can underly diabetes insipidus. However, transcriptomic and phosphoproteomic advances have revealed a diverse repertoire of understudied GPCRs expressed in the collecting duct whose physiological roles remain largely undefined. Here, we review emerging insights into three such receptors-GPR39, ADGRF5, and ADGRG3-highlighting their distinct contributions to collecting duct function. We also discuss atypical GPCR-related signaling, including PKD1 and MAGED2, which expand the conceptual framework of GPCR biology in renal function. Collectively, these findings illustrate that GPCRs play diverse and underappreciated roles in collecting duct physiology and pathophysiology, and that continued mechanistic studies may uncover new therapeutic opportunities for kidney disease.

Identifiers

PMID41996347
PMCPMC13108524

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.